Antibody translation across species offers a compelling strategy to extend the vast and expensive investments in human therapeutic antibodies to veterinary oncology, with applications in both veterinary medicine and comparative oncology. While precise, low-immunogenic treatments are essential for canine cancer care, traditional species conversion methods rely on ad hoc bioinformatics modifications. These methods often implicitly decouple the framework (FR) and complementarity-determining regions (CDRs), ignoring how structural changes in FRs can affect the conformation and function of CDRs. This can compromise binding specificity and require costly high-throughput in vitro screening. To address this, we present DoggifAI, a transformer model that translates non-canine antibody sequences into canine ones by generating species-appropriate framework regions (FRs) based on desired CDRs. This allows the model to better preserve structural compatibility between FRs and CDRs. The model is pretrained in a T5-style text-to-text denoising task on a large multispecies antibody dataset, which allows further finetuning on a much smaller species-specific dataset. DoggifAI generates highly canine-like antibodies and shows promising results in preserving binding specificity. To support further progress in this field, we also release a curated dataset of over 430,000 unique canine antibody chain sequences, significantly expanding the public sequence repertoire.
No takes yet. Share an insight, caveat, or question.
Grabarczyk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: